Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00379795
Status:
COMPLETED
Last Update Posted:
2017-05-11
First Post:
2006-09-21
Brief Title:
An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Organization Data
Organization:
Genentech Inc
Class:
INDUSTRY
Study ID:
FVF3426g Cohort 1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genentech Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None